We are thrilled to announce the launch of the Journal of Health Advocacy (JHA), the first of its kind peer-reviewed open access journal housed within the organization’s Patrick M. Magoon Institute for Healthy Communities https://t.co/vsq43sZ6zJ.
Long before the release of their lifesaving COVID-19 vaccines, #RareDisease researchers @moderna_tx were developing mRNA therapies for rare metabolic disorders that currently have no other treatments.
@sci_steph spoke with Paolo Martini to learn more:
https://t.co/pdoX6rg4bJ
The very last presentation at #SIMD2024 with more to come for GMDI: a moving panel on the importance of patient advocacy in IEM life. Thank you for all you do for each other and for us.
On this rare disease day, I’m in a strategy meeting with clinicians, scientists and most importantly, the families and parents of the kids we’re tryin to help. #RareDiseaseDay2024#RareDiseaseDay
In Latin America, 75% of rare disease patients lack a definitive diagnosis. How is addressing the diagnostic odyssey key to ensuring patients live healthier, more fulfilled lives? Read our report supported by @AstraZeneca https://t.co/BsomjHszUz
#rarediseaseday#showyourstripes
¿Te interesa apoyar la investigación de #EnfermedadesRaras y facilitar el diagnóstico molecular de pacientes en México? Ahora ya puedes donar para apoyar la secuenciación genómica de pacientes mexicanos que viven con enfermedades genéticas.
https://t.co/5FWCHSg3cz
🚨 IT'S RARE DISEASE DAY GLOBALLY! 🚨 Join us marking #RareDiseaseDay 2024! Spread awareness, share stories, and support those living with rare diseases. Together, we make a lasting impact! #ShareYourColours